荷兰乳腺癌放疗质量透明化:一项放疗参数的国家登记
本文描述荷兰全国乳腺癌放疗参数登记系统(NBCA-R)的建立过程,由荷兰放疗学会乳腺癌平台工作组选定剂量体积参数作为肿瘤控制和毒性的替代结局指标,并在6家放疗机构开展两项试点研究。第一项试点(N=1093)已发现各机构间部分乳腺照射应用比例(0至17%)和瘤床加量比例(26.5%至70.2%)存在差异,左乳或胸壁照射患者平均心脏平均剂量为0.80至1.82 Gy。第二项试点在6个科室日常实践中实施了DICOM-RT自动上传模块。
要点
- NBCA-R为荷兰所有接受至少手术和放疗的乳腺癌患者的结构性全国放疗参数登记系统。
- 第一项试点(N=1093)显示6家机构间部分乳腺照射应用比例为0至17%,瘤床加量比例为26.5%至70.2%。
- 左乳或胸壁照射患者平均心脏平均剂量在各机构间为0.80至1.82 Gy,乳腺或胸壁照射患者平均肺平均剂量为2.06至3.3 Gy。
核心结论
- 已制定一套放疗参数集并对荷兰所有乳腺癌患者实施登记,使用自动上传模块可最小化登记负担;基于NBCA-R数据将开展实践差异分析,最终目标是改善乳腺癌放疗质量。
研究设计与样本
- 由荷兰放疗学会乳腺癌平台代表组成的工作组选定剂量体积参数作为肿瘤控制和毒性的替代结局参数,并在6家放疗机构开展两项试点研究。
- 第一项试点研究将数据手动录入安全网络系统,第二项试点研究创建并测试了DICOM-RT自动上传模块。
- NBCA-R数据集通过选取描述给予剂量、靶区体积、覆盖度和均匀性以及危及器官剂量的放疗参数而建立,数据录入对所有荷兰放疗科室为强制要求。
主要发现
- 第一项试点研究(N=1093)已检测到相当大的差异:6家机构间部分乳腺照射应用比例从0至17%不等,瘤床加量比例从26.5%至70.2%不等。
- 对于仅接受左乳或胸壁照射的患者,各机构平均心脏平均剂量从0.80至1.82 Gy不等;对于仅接受乳腺或胸壁照射的患者,平均肺平均剂量从2.06至3.3 Gy不等。
- 第二项试点研究中6个科室在日常实践中实施了DICOM-RT上传模块,匿名数据将通过FAIR框架供研究人员使用。
局限性
- 试验为回顾性注册。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiotherapy (RT) is part of the curative treatment of approximately 70% of breast cancer (BC) patients. Wide practice variation has been reported in RT dose, fractionation and its treatment planning for BC. To decrease this practice variation, it is essential to first gain insight into the current variation in RT treatment between institutes. This paper describes the development of the NABON Breast Cancer Audit-Radiotherapy (NBCA-R), a structural nationwide registry of BC RT data of all BC patients treated with at least surgery and RT. METHODS: A working group consisting of representatives of the BC Platform of the Dutch Radiotherapy Society selected a set of dose volume parameters deemed to be surrogate outcome parameters, both for tumour control and toxicity. Two pilot studies were carried out in six RT institutes. In the first pilot study, data were manually entered into a secured web-based system. In the second pilot study, an automatic Digital Imaging and Communications in Medicine (DICOM) RT upload module was created and tested. RESULTS: The NBCA-R dataset was created by selecting RT parameters describing given dose, target volumes, coverage and homogeneity, and dose to organs at risk (OAR). Entering the data was made mandatory for all Dutch RT departments. In the first pilot study (N = 1093), quite some variation was already detected. Application of partial breast irradiation varied from 0 to 17% between the 6 institutes and boost to the tumour bed from 26.5 to 70.2%. For patients treated to the left breast or chest wall only, the average mean heart dose (MHD) varied from 0.80 to 1.82 Gy; for patients treated to the breast/chest wall only, the average mean lung dose (MLD) varied from 2.06 to 3.3 Gy. In the second pilot study 6 departments implemented the DICOM-RT upload module in daily practice. Anonymised data will be available for researchers via a FAIR (Findable, Accessible, Interoperable, Reusable) framework. CONCLUSIONS: We have developed a set of RT parameters and implemented registration for all Dutch BC patients. With the use of an automated upload module registration burden will be minimized. Based on the data in the NBCA-R analyses of the practice variation will be done, with the ultimate aim to improve quality of BC RT. Trial registration Retrospectively registered.
引用
- Maliko N, Stam MR, Boersma LJ, et al. Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters. Radiat Oncol. 2022. PMID: 35413924. doi:10.1186/s13014-022-02043-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。